Drug Type Antibody drug conjugate (ADC) |
Synonyms anti-CD22-NMS-249 (Genentech), anti-CD22-NMS-249 (Genentech/Nerviano Medical Sciences) |
Target |
Action inhibitors |
Mechanism CD22 inhibitors(CD22 inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Preclinical | United States | - | |
Non-Hodgkin Lymphoma | Preclinical | Italy | - |